Signaturefd LLC Trims Stock Holdings in Koninklijke Philips (NYSE:PHG)

Signaturefd LLC lowered its holdings in Koninklijke Philips (NYSE:PHG) by 5.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 26,856 shares of the technology company’s stock after selling 1,545 shares during the period. Signaturefd LLC’s holdings in Koninklijke Philips were worth $680,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. PNC Financial Services Group Inc. raised its stake in Koninklijke Philips by 4.8% during the third quarter. PNC Financial Services Group Inc. now owns 36,291 shares of the technology company’s stock valued at $1,187,000 after buying an additional 1,676 shares in the last quarter. West Family Investments Inc. acquired a new stake in Koninklijke Philips during the third quarter valued at approximately $252,000. Charles Schwab Investment Management Inc. raised its stake in Koninklijke Philips by 26.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 55,290 shares of the technology company’s stock valued at $1,809,000 after buying an additional 11,538 shares in the last quarter. Cerity Partners LLC raised its stake in Koninklijke Philips by 16.8% during the third quarter. Cerity Partners LLC now owns 60,112 shares of the technology company’s stock valued at $1,967,000 after buying an additional 8,625 shares in the last quarter. Finally, Pitcairn Co. acquired a new stake in Koninklijke Philips during the third quarter valued at approximately $256,000. Hedge funds and other institutional investors own 13.67% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on PHG shares. BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday, February 25th. UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. Finally, StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday, March 8th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

Koninklijke Philips Stock Up 1.9 %

Shares of Koninklijke Philips stock opened at $26.79 on Thursday. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. The business’s 50 day simple moving average is $26.73 and its 200-day simple moving average is $27.78. The stock has a market capitalization of $25.18 billion, a price-to-earnings ratio of -31.89, a PEG ratio of 0.82 and a beta of 0.78. Koninklijke Philips has a twelve month low of $19.10 and a twelve month high of $32.91.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The company had revenue of $5.38 billion for the quarter, compared to analyst estimates of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. Equities research analysts forecast that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The firm also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be issued a $0.886 dividend. This represents a yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio (DPR) is -89.29%.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.